Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript - Thomson StreetEvents

Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript

Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript - Thomson StreetEvents
Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript
Published Nov 14, 2023
8 pages (4161 words) — Published Nov 14, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ITRM.OQ earnings conference call or presentation 14-Nov-23 1:30pm GMT

  
Brief Excerpt:

...Operator Hello, everyone, and welcome to the Iterum Therapeutics third-quarter 2023 financial results and business update. My name is Harry, and I'll be your operator today. (Operator Instructions) And I will now hand the call over to Louise Barrett, Senior Vice President, Legal Affairs. To begin, please go ahead. Louise Barrett ...

  
Report Type:

Transcript

Source:
Company:
Iterum Therapeutics PLC
Ticker
Time
1:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Thomas Yip - H.C. Wainwright & Co, LLC - Analyst : Hi, good morning. This is Thomas Yip asking a couple of questions for Ed. Thank you so much for the kind of questions. So, first, perhaps a discussion for the Phase 2 study with over 2,200 patients enrolled versus the target of 1966 and also Korea, as you mentioned earlier, one quarter ahead, very impressive. Can you discuss what the main drivers of this open enrollment and also accelerated pace was some initial feedback for this study?


Question: Thomas Yip - H.C. Wainwright & Co, LLC - Analyst : Got it. And then trying to narrow down the early first quarter 2024, readout timeline a little bit? Or would this be a kind of January or late January, February timeframe?


Question: Thomas Yip - H.C. Wainwright & Co, LLC - Analyst : Understood, understood. Let's Just one more question from us or we've seen us she announce multiple new patent issue both in US and ex-US. Can discuss where some actions (inaudible) for ex U.S. markets?


Question: Thomas Yip - H.C. Wainwright & Co, LLC - Analyst : Understood. Thank you again for taking your questions and we look forward to the data readout in first quarter. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 14, 2023 / 1:30PM, ITRM.OQ - Q3 2023 Iterum Therapeutics PLC Earnings Call

Table Of Contents

Iterum Therapeutics PLC Q1 2025 Earnings Call Transcript – 2025-05-13 – US$ 106.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 13-May-25 12:30pm GMT

Iterum Therapeutics PLC Q4 2024 Earnings Call Transcript – 2025-02-07 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 7-Feb-25 1:30pm GMT

Iterum Therapeutics PLC Q3 2024 Earnings Call Transcript – 2024-11-14 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 14-Nov-24 1:30pm GMT

Iterum Therapeutics PLC Conference Call Transcript – 2024-10-28 – US$ 54.00 – Edited Transcript of ITRM.OQ conference call or presentation 28-Oct-24 12:30pm GMT

Iterum Therapeutics PLC Q4 2023 Earnings Call Transcript – 2024-03-28 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 28-Mar-24 12:30pm GMT

Iterum Therapeutics PLC Q2 2023 Earnings Call Transcript – 2023-08-11 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 11-Aug-23 12:30pm GMT

Iterum Therapeutics PLC Q4 2022 Earnings Call Transcript – 2023-03-16 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 16-Mar-23 12:30pm GMT

Iterum Therapeutics PLC at SRAX Sequire Biotechnology Conference (Virtual) Transcript – 2023-02-02 – US$ 54.00 – Edited Transcript of ITRM.OQ presentation 2-Feb-23 7:30pm GMT

Iterum Therapeutics PLC Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 10-Nov-22 1:30pm GMT

Iterum Therapeutics PLC Q4 2021 Earnings Call Transcript – 2022-03-28 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 28-Mar-22 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript" Nov 14, 2023. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Iterum-Therapeutics-PLC-Earnings-Call-T15799286>
  
APA:
Thomson StreetEvents. (2023). Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript Nov 14, 2023. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Iterum-Therapeutics-PLC-Earnings-Call-T15799286>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.